Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.038 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |